Practical Considerations for Aseptic Gowning in Contamination Control Strategies
Join this webinar as we examine the main personnel-related factors that could lead to particle/microbial contamination risks of the product and outline practical measures that can mitigate these risks.
Sterile product manufacturing is a critical process that requires the application of stringent controls and compliance with specific requirements to minimize the risks of contamination. Personnel introduce particles and microbes shed from skin, hair, and clothing. A comprehensive Contamination Control Strategy (CCS) must therefore evaluate all factors that could allow personnel to introduce contaminants into the process.
As highlighted in the most recent version of EU GMP Annex 1 (2022), a CCS should be implemented to identify and analyze the overall risk of contamination in the facility and to propose and review appropriate mitigating actions (e.g., corrective and/or preventive action plans). Within a pharmaceutical CCS, all potential sources of contamination must be considered, with personnel consistently recognized as one of the most significant contributors to risk.
Register today to secure your spot! >>>
Key “personnel” factors that can pose microbiological or particulate contamination risks include, at minimum:
- Gowning
- Qualification and training
- Flow
- Intervention
- Personnel monitoring
Key learning points:
- Assessing Personnel-Related Contamination Risks
- Gowning
- Other Personnel Factors
- How to develop a CCS that includes these crucial considerations
REGISTER NOW >>>
OUR SPEAKERS
Rosa Laronga, Advisory Specialist at Particle Measuring Systems
Rosa Laronga is a doctor in Pharmacy with a solid scientific background developed over several years of experience in pharmaceutical companies. She started her career in Quality, overseeing production activities. Later she took on roles in Quality Assurance and Sterility Assurance, where she gained expertise in environmental monitoring, deviation management, and the preparation of technical documentation. Now, at PMS, as an Advisory Specialist, she supports pharmaceutical companies in improving their sterility assurance approaches through the implementation of contamination control strategies, environmental monitoring risk assessments and training on sterility assurance topic
FAQs
Is the webinar free?
Yes – there is no charge to watch the panel discussion, either live or on-demand.
When will the webinar take place?
25 February 2026, 15:00 UK time
Can I watch it later?
The session will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end.
